2. Signaling Pathways
  3. Antibody-drug Conjugate/ADC Related
  4. Drug-Linker Conjugates for ADC
  5. Daunorubicins/Doxorubicins Isoform

Daunorubicins/Doxorubicins

 

Daunorubicins/Doxorubicins Related Products (6):

Cat. No. Product Name Effect Purity
  • HY-116063
    Doxorubicin-SMCC
    		99.48%
    Doxorubicin-SMCC is a drug-linker conjugate for ADC.
  • HY-16261B
    MC-DOXHZN hydrochloride
    		≥98.0%
    MC-DOXHZN ((E/Z)-Aldoxorubicin) hydrochloride is an albumin-binding prodrug of Doxorubicin (DNA topoisomerase II inhibitor), with acid-sensitive properties.
  • HY-126683
    Mal-C6-α-Amanitin
    Mal-C6-α-Amanitin is a drug-linker conjugate for ADC with potent antitumor activity by using α-Amanitin (an RNA polymerase II inhibitor), linked via the ADC linker Mal-C6.
  • HY-136288
    Azide-PEG4-VC-PAB-Doxorubicin
    		98.47%
    Azide-PEG4-VC-PAB-Doxorubicin is a drug-linker conjugate composed of a cytotoxic anthracycline antibiotic Doxorubicin and a linker Azide-PEG4-VC-PAB to make antibody drug conjugate (ADC).
  • HY-16261A
    MC-DOXHZN
    MC-DOXHZN ((E/Z)-Aldoxorubicin) is an albumin-binding prodrug of Doxorubicin (DNA topoisomerase II inhibitor), with acid-sensitive properties.
  • HY-128959
    MCC-Modified Daunorubicinol
    Daunorubicinol is a drug-linker conjugate for ADC with potent antitumor activity by using Aur0101 (DNA Topoisomerase II inhibitor), linked via the ADC linker.